Report cover image

Global Children Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 195 Pages
SKU # APRC20355375

Description

Summary

According to APO Research, The global Children Influenza Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Children Influenza Vaccine include BCHT, CCBIO, CSL, Hulan Bio, KM Biologics, Sanofi Pasteur, Sinovac, Viatris and AstraZeneca, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Children Influenza Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Children Influenza Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Children Influenza Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Children Influenza Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Children Influenza Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Children Influenza Vaccine sales, projected growth trends, production technology, application and end-user industry.

Children Influenza Vaccine Segment by Company

BCHT
CCBIO
CSL
Hulan Bio
KM Biologics
Sanofi Pasteur
Sinovac
Viatris
AstraZeneca
GSK
Jiangsu GDK
Children Influenza Vaccine Segment by Type

Nasal Spray
Injection
Children Influenza Vaccine Segment by Application

Public
Private
Children Influenza Vaccine Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Children Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Children Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Children Influenza Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Children Influenza Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Children Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Children Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Children Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Children Influenza Vaccine Market Size, 2020 VS 2024 VS 2031
1.3 Global Children Influenza Vaccine Market Size Estimates and Forecasts (2020-2031)
1.4 Global Children Influenza Vaccine Sales Estimates and Forecasts (2020-2031)
1.5 Global Children Influenza Vaccine Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Children Influenza Vaccine Market Dynamics
2.1 Children Influenza Vaccine Industry Trends
2.2 Children Influenza Vaccine Industry Drivers
2.3 Children Influenza Vaccine Industry Opportunities and Challenges
2.4 Children Influenza Vaccine Industry Restraints
3 Children Influenza Vaccine Market by Manufacturers
3.1 Global Children Influenza Vaccine Revenue by Manufacturers (2020-2025)
3.2 Global Children Influenza Vaccine Sales by Manufacturers (2020-2025)
3.3 Global Children Influenza Vaccine Average Sales Price by Manufacturers (2020-2025)
3.4 Global Children Influenza Vaccine Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Children Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Children Influenza Vaccine Manufacturers, Product Type & Application
3.7 Global Children Influenza Vaccine Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Children Influenza Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Children Influenza Vaccine Players Market Share by Revenue in 2024
3.8.3 2024 Children Influenza Vaccine Tier 1, Tier 2, and Tier 3
4 Children Influenza Vaccine Market by Type
4.1 Children Influenza Vaccine Type Introduction
4.1.1 Nasal Spray
4.1.2 Injection
4.2 Global Children Influenza Vaccine Sales by Type
4.2.1 Global Children Influenza Vaccine Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Children Influenza Vaccine Sales by Type (2020-2031)
4.2.3 Global Children Influenza Vaccine Sales Market Share by Type (2020-2031)
4.3 Global Children Influenza Vaccine Revenue by Type
4.3.1 Global Children Influenza Vaccine Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Children Influenza Vaccine Revenue by Type (2020-2031)
4.3.3 Global Children Influenza Vaccine Revenue Market Share by Type (2020-2031)
5 Children Influenza Vaccine Market by Application
5.1 Children Influenza Vaccine Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Children Influenza Vaccine Sales by Application
5.2.1 Global Children Influenza Vaccine Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Children Influenza Vaccine Sales by Application (2020-2031)
5.2.3 Global Children Influenza Vaccine Sales Market Share by Application (2020-2031)
5.3 Global Children Influenza Vaccine Revenue by Application
5.3.1 Global Children Influenza Vaccine Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Children Influenza Vaccine Revenue by Application (2020-2031)
5.3.3 Global Children Influenza Vaccine Revenue Market Share by Application (2020-2031)
6 Global Children Influenza Vaccine Sales by Region
6.1 Global Children Influenza Vaccine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Children Influenza Vaccine Sales by Region (2020-2031)
6.2.1 Global Children Influenza Vaccine Sales by Region (2020-2025)
6.2.2 Global Children Influenza Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Children Influenza Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Children Influenza Vaccine Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Children Influenza Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Children Influenza Vaccine Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Children Influenza Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Children Influenza Vaccine Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Children Influenza Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Children Influenza Vaccine Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Children Influenza Vaccine Revenue by Region
7.1 Global Children Influenza Vaccine Revenue by Region
7.1.1 Global Children Influenza Vaccine Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Children Influenza Vaccine Revenue by Region (2020-2025)
7.1.3 Global Children Influenza Vaccine Revenue by Region (2026-2031)
7.1.4 Global Children Influenza Vaccine Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Children Influenza Vaccine Revenue (2020-2031)
7.2.2 North America Children Influenza Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Children Influenza Vaccine Revenue (2020-2031)
7.3.2 Europe Children Influenza Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Children Influenza Vaccine Revenue (2020-2031)
7.4.2 Asia-Pacific Children Influenza Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Children Influenza Vaccine Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Children Influenza Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 BCHT
8.1.1 BCHT Comapny Information
8.1.2 BCHT Business Overview
8.1.3 BCHT Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 BCHT Children Influenza Vaccine Product Portfolio
8.1.5 BCHT Recent Developments
8.2 CCBIO
8.2.1 CCBIO Comapny Information
8.2.2 CCBIO Business Overview
8.2.3 CCBIO Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 CCBIO Children Influenza Vaccine Product Portfolio
8.2.5 CCBIO Recent Developments
8.3 CSL
8.3.1 CSL Comapny Information
8.3.2 CSL Business Overview
8.3.3 CSL Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 CSL Children Influenza Vaccine Product Portfolio
8.3.5 CSL Recent Developments
8.4 Hulan Bio
8.4.1 Hulan Bio Comapny Information
8.4.2 Hulan Bio Business Overview
8.4.3 Hulan Bio Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Hulan Bio Children Influenza Vaccine Product Portfolio
8.4.5 Hulan Bio Recent Developments
8.5 KM Biologics
8.5.1 KM Biologics Comapny Information
8.5.2 KM Biologics Business Overview
8.5.3 KM Biologics Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 KM Biologics Children Influenza Vaccine Product Portfolio
8.5.5 KM Biologics Recent Developments
8.6 Sanofi Pasteur
8.6.1 Sanofi Pasteur Comapny Information
8.6.2 Sanofi Pasteur Business Overview
8.6.3 Sanofi Pasteur Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Sanofi Pasteur Children Influenza Vaccine Product Portfolio
8.6.5 Sanofi Pasteur Recent Developments
8.7 Sinovac
8.7.1 Sinovac Comapny Information
8.7.2 Sinovac Business Overview
8.7.3 Sinovac Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Sinovac Children Influenza Vaccine Product Portfolio
8.7.5 Sinovac Recent Developments
8.8 Viatris
8.8.1 Viatris Comapny Information
8.8.2 Viatris Business Overview
8.8.3 Viatris Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Viatris Children Influenza Vaccine Product Portfolio
8.8.5 Viatris Recent Developments
8.9 AstraZeneca
8.9.1 AstraZeneca Comapny Information
8.9.2 AstraZeneca Business Overview
8.9.3 AstraZeneca Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 AstraZeneca Children Influenza Vaccine Product Portfolio
8.9.5 AstraZeneca Recent Developments
8.10 GSK
8.10.1 GSK Comapny Information
8.10.2 GSK Business Overview
8.10.3 GSK Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 GSK Children Influenza Vaccine Product Portfolio
8.10.5 GSK Recent Developments
8.11 Jiangsu GDK
8.11.1 Jiangsu GDK Comapny Information
8.11.2 Jiangsu GDK Business Overview
8.11.3 Jiangsu GDK Children Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Jiangsu GDK Children Influenza Vaccine Product Portfolio
8.11.5 Jiangsu GDK Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Children Influenza Vaccine Value Chain Analysis
9.1.1 Children Influenza Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Children Influenza Vaccine Production Mode & Process
9.2 Children Influenza Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Children Influenza Vaccine Distributors
9.2.3 Children Influenza Vaccine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.